As expected, the expression of sema3A on B reg cells was significantly lower in SLE patients when compared to those in healthy individuals, thereby suggesting that this finding is partially responsible for B cell auto-reactivity in SLE (6). The gene discussed is SEMA3A; the disease is systemic lupus erythematosus.